WellCare Health Plans, Inc. (WCG)
(Delayed Data from NYSE)
$261.50 USD
+1.83 (0.70%)
Updated May 3, 2019 04:01 PM ET
After-Market: $261.37 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.50 USD
+1.83 (0.70%)
Updated May 3, 2019 04:01 PM ET
After-Market: $261.37 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Has WellCare Health Plans (WCG) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (WCG) Outperforming Other Medical Stocks This Year?
Why Hold Strategy is Apt for Universal Health (UHS) Now
by Zacks Equity Research
Universal Health (UHS) is well-positioned to reap benefits for investors on the back of its rising top line, capital strength and solid performances at both Acute Care and Behavioral Health segments.
New Strong Buy Stocks for January 16th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
UnitedHealth (UNH) Q4 Earnings Beat on Revenue Growth
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results reflect strong contribution from its health benefits and service segments.
Why Should You Retain MEDNAX (MD) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on its rising revenue stream and inorganic growth profile, MEDNAX (MD) holds potential to benefit its investors.
Why WellCare (WCG) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
WellCare (WCG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cigna, Oscar Team Up to Offer Health Aids to Small Businesses
by Zacks Equity Research
Cigna (CI) partners with Oscar to provide health solutions for small businesses.
These 5 Stocks Boast Impressive Interest Coverage Ratio
by Sumit Singh
A company's creditworthiness depends on how effectively it meets interest obligations. One that is capable of generating earnings well above its interest expense can withstand financial hardships.
Molina Healthcare to Boost Medicaid Via Strategic Buyout
by Zacks Equity Research
Molina Healthcare (MOH) aims to scale up its Medicaid business by acquiring NextLevel Health.
WellCare (WCG) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
WellCare (WCG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
WellCare Health Plans (WCG) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
In the latest trading session, WellCare Health Plans (WCG) closed at $331.27, marking no change from the previous day.
Is WellCare Health Plans (WCG) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (WCG) Outperforming Other Medical Stocks This Year?
Why Should You Retain Molina Healthcare in Your Portfolio?
by Zacks Equity Research
On the back of its restructuring initiatives and solid membership, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
Humana (HUM) Grows on Strong Medicare Business Expansion
by Zacks Equity Research
Humana (HUM) thrives well on the back of its well-performing Medicare business.
Pick These 5 Stocks With Superb Interest Coverage Ratio
by Sumit Singh
Interest coverage ratio is used to determine how effectively a company can pay the interest charged on its debt.
WellCare Health Plans (WCG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, WellCare Health Plans (WCG) closed at $331.30, marking a +0.28% move from the previous day.
3 Reasons Growth Investors Will Love WellCare (WCG)
by Zacks Equity Research
WellCare (WCG) could produce exceptional returns because of its solid growth attributes.
Is WellCare Health Plans (WCG) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (WCG) Outperforming Other Medical Stocks This Year?
Cigna to Divest Non-Health Unit, Streamline Operations
by Zacks Equity Research
Cigna (CI) announces sale of its Group Life and Disability business to focus on debt reduction and core business of healthcare.
WellCare Health, Fitbit Collaborate to Aid Diabetes Patients
by Zacks Equity Research
WellCare Health (WCG) and Fitbit team up to encourage Georgia-based WellCare Medicaid members to manage their diabetic condition.
Ensign Group (ENSG) Takes Shareholder-Friendly Initiatives
by Zacks Equity Research
Ensign Group (ENSG) clears a quarterly dividend hike to share more profits with investors.
Fitbit (FIT) Partners WellCare to Reduce Type 2 Diabetes
by Zacks Equity Research
Fitbit (FIT) partners with WellCare in a bid to expand its share in the healthcare market.
WellCare Health Plans (WCG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, WellCare Health Plans (WCG) closed at $317.15, marking a -1.11% move from the previous day.
Humana (HUM) to Take Over Enclara for Enriched Healthcare
by Zacks Equity Research
Humana (HUM) to acquire hospice pharmacy Enclara Healthcare for boosting its capabilities.
Tenet Healthcare to Divest Units for Streamlining Operations
by Zacks Equity Research
Tenet Healthcare (THC) to sell its Memphis area units for clearing its debt and focusing on core business.